Characterization of unresectable cholangiocarcinoma patients treated with or without chemoradiation

被引：0
|
作者：
Rogers, Jane Elizabeth
Van Nguyen
Nogueras-Gonzalez, Graciela M.
Crane, Christopher H.
Das, Prajnan
Krishnan, Sunil
Law, Lindsey
Javle, Milind M.
Kaseb, Ahmed Omar
Shroff, Rachna T.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Pharm Clin Programs, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 03期
关键词：
D O I：
10.1200/jco.2015.33.3_suppl.403
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
403
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Definitive Chemoradiation Therapy in the Treatment of Unresectable Intrahepatic Cholangiocarcinoma: A National Cancer Data Base Study
    Ghiassi-Nejad, Z.
    Moshier, E.
    Schwartz, M.
    Buckstein, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E211 - E212
  • [22] The pattern of recurrence in esophageal cancer patients treated with concurrent chemoradiation with or without surgery
    Liengsawangwong, R.
    Liu, H. H.
    Bucci, M. K.
    Allen, P. K.
    Khan, M.
    Jeter, M.
    O'Reilly, M.
    Kornaki, R.
    Cox, J. D.
    Liao, Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S245 - S245
  • [23] Predictors of Cardiac Toxicity in Operable Esophageal Cancer Patients Treated with or Without Chemoradiation
    Witt, J. S.
    Jagodinsky, J. C.
    Liu, Y.
    Yadav, P.
    Kuczmarska-Haas, A.
    Maloney, J. D.
    Yu, M.
    Ritter, M. A.
    Bassetti, M. F.
    Baschnagel, A. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E44 - E45
  • [24] External Beam Radiation Therapy With or Without Concurrent Chemotherapy for Patients with Unresectable Locally Advanced Hilar Cholangiocarcinoma
    Chen, San-Chi
    Chen, Ming-Huang
    Li, Chung-Pin
    Chen, Ming-Han
    Chang, Peter Mu-Hsin
    Liu, Chun-Yu
    Tzeng, Cheng-Hwai
    Liu, Yu-Ming
    Yen, Sang-Hue
    Chao, Yee
    Huang, Pin-I
    HEPATO-GASTROENTEROLOGY, 2015, 62 (137) : 102 - 107
  • [25] A case of unresectable combined hepatocellular and cholangiocarcinoma treated with atezolizumab plus bevacizumab
    Saito, Naoto
    Hatanaka, Takeshi
    Nakano, Sachi
    Hazama, Yoichi
    Yoshida, Sachiko
    Hachisu, Yoko
    Tanaka, Yoshiki
    Yoshinaga, Teruo
    Kashiwabara, Kenji
    Norio, Kubo
    Hosouchi, Yasuo
    Tojima, Hiroki
    Kakizaki, Satoru
    Uraoka, Toshio
    CLINICAL CASE REPORTS, 2022, 10 (07):
  • [26] Clinical Outcomes in Unresectable Cholangiocarcinoma Treated With Stereotactic Body Radiation Therapy
    Sandler, K. A.
    Veruttipong, D.
    Agopian, V.
    Finn, R.
    Hong, J.
    Kaldas, F.
    Sadeghi, S.
    Busuttil, R.
    Lee, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E140 - E140
  • [27] A Case of Unresectable Combined Hepatocellular-Cholangiocarcinoma Successfully Treated with Lenvatinib
    Osuga, Takahiro
    Miyanishi, Koji
    Ito, Ryo
    Tanaka, Shingo
    Hamaguchi, Kota
    Ohnuma, Hiroyuki
    Murase, Kazuyuki
    Takada, Kohichi
    Nagayama, Minoru
    Kimura, Yasutoshi
    Sugawara, Taro
    Sugita, Shintaro
    Takemasa, Ichiro
    Hasegawa, Tadashi
    Kato, Junji
    CASE REPORTS IN ONCOLOGY, 2022, 15 (01): : 318 - 325
  • [28] Impact of adjuvant chemoradiation on survival in patients with resectable cholangiocarcinoma
    Dover, Laura L.
    Oster, Robert A.
    McDonald, Andrew M.
    DuBay, Derek A.
    Wang, Thomas N.
    Jacob, Rojymon
    HPB, 2016, 18 (10) : 843 - 850
  • [29] DOES AN OPTIMAL STRATEGY EXIST FOR PATIENTS WITH UNRESECTABLE CHOLANGIOCARCINOMA
    ROSLYN, JJ
    MAYO CLINIC PROCEEDINGS, 1995, 70 (05) : 503 - 504
  • [30] Outcome of Transplant-fallout Patients With Unresectable Cholangiocarcinoma
    Sio, Terence T.
    Martenson, James A., Jr.
    Haddock, Michael G.
    Novotny, Paul J.
    Gores, Gregory J.
    Alberts, Steven R.
    Miller, Robert C.
    Heimbach, Julie K.
    Rosen, Charles B.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2016, 39 (03): : 271 - 275
12345